Speech delay was documented in 94% of individuals with pathogenic TNRC6B variants, followed by other forms of developmental delay, intellectual disability, ASD, ADHD, behavioral abnormalities, musculoskeletal abnormalities, and dysmorphic features (Granadillo et al. 2020). The gene discussed is TNRC6B; the disease is Delayed speech and language development.